Related Experiment Video
Updated: Mar 11, 2026

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
1.3K
Necrotizing tracheobronchitis associated with rheumatoid arthritis.
Shigehisa Kajikawa1, Kazushi Noda2, Yasuhiro Nozaki2
1Department of Respiratory Medicine, Tokoname Municipal Hospital, Japan.
Respiratory Medicine Case Reports
|November 30, 2016
Summary
This case study highlights necrotizing tracheobronchitis in a rheumatoid arthritis patient. Systemic inflammation from rheumatoid arthritis caused the rare airway condition, treated successfully with steroids.
Area of Science:
- Pulmonology
- Rheumatology
- Pathology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease primarily affecting joints.
- Airway involvement in RA is uncommon but can manifest as various pathologies.
- Necrotizing tracheobronchitis is a severe inflammatory condition of the trachea and bronchi.
Observation:
- A 64-year-old male with rheumatoid arthritis presented with worsening respiratory symptoms initially misdiagnosed as community-acquired pneumonia.
- Bronchoscopy revealed necrotic tissue and white, soft lesions in the trachea and bronchi.
- Transbronchial biopsy confirmed necrotic tissue with squamous metaplasia and inflammatory infiltrate.
Findings:
- The patient exhibited high levels of rheumatoid factor and anti-cyclic citrullinated peptide antibodies, confirming rheumatoid arthritis.
- Necrotizing tracheobronchitis was diagnosed as a manifestation of systemic inflammation associated with rheumatoid arthritis.
- The respiratory condition showed acute exacerbation unresponsive to initial antibiotic therapy.
Implications:
- This case underscores the importance of considering systemic autoimmune conditions in unexplained respiratory symptoms.
- Necrotizing tracheobronchitis in the context of rheumatoid arthritis requires a tailored treatment approach.
- Steroid therapy proved effective in managing the airway inflammation and improving respiratory status in this patient.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
717
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
717
Trachea
5.7K
The trachea, commonly known as the windpipe, is a vital part of the human respiratory system. It serves as a passageway for air to travel between the larynx and the bronchi, allowing oxygen to reach the lungs. Let's explore its anatomical features, dimensions, layers of the tracheal wall, associated muscles, and the functions of its parts.
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of...
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of...
5.7K
Acute Respiratory Failure-III
1.1K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.1K
Acute Respiratory Failure-II
1.4K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.4K
Acute Respiratory Failure-V
591
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
591
Acute Respiratory Failure-I
1.3K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.3K

